Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer
211 A discovery-to-therapeutics platform for functional antibody targeting of complex membrane-embedded tumor antigens: validation with claudin family members
4 affiliations
- 1Celularity, Florham Park, NJ, USA
- 2Laboratory Animal Center, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia
- 31Icosagen Cell Factory OÜ, Tartu, Tartumaa, Estonia
- 4Icosagen Cell Factory OÜ, Tartu, Tartumaa, Estonia
Related
- A scalable Zebrafish Platform for genetic validation and functional discovery of stage-specific breast cancer metastasis regulators
- Targeting IL-2 to inflamed tissues via oxidation-specific epitopes enables third-generation bispecific IL-2 therapeutics
- Targeting PRMT5 Across Cancers and AI-Driven Discovery of Candidate Compounds
- Discovery of broad-spectrum antivirals targeting viral proteases using in silico structural modeling and cellular analysis
- Discovery of direct-acting small-molecule RIG-I agonists through creation of a selective CARD activation platform
BibTeX
@article{mahlakoiv2026discoverytotherapeutics,
title = {{211 A discovery-to-therapeutics platform for functional antibody targeting of complex membrane-embedded tumor antigens: validation with claudin family members}},
author = {Tanel Mahlakõiv and Nayana Gaur and Siret Tahk and Joan Teyra and Ana Shahpazir and Mart Ustav and Paule Hermet-Teesalu and Robin Pau and Kai Virumäe and Sebastian Zoll and Anu Ustav},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2026},
month = nov,
doi = {10.1136/jitc-2026-sitc2026.0211},
url = {https://doi.org/10.1136/jitc-2026-sitc2026.0211},
note = {CC BY},
}
RIS
TY - JOUR
TI - 211 A discovery-to-therapeutics platform for functional antibody targeting of complex membrane-embedded tumor antigens: validation with claudin family members
AU - Tanel Mahlakõiv
AU - Nayana Gaur
AU - Siret Tahk
AU - Joan Teyra
AU - Ana Shahpazir
AU - Mart Ustav
AU - Paule Hermet-Teesalu
AU - Robin Pau
AU - Kai Virumäe
AU - Sebastian Zoll
AU - Anu Ustav
PY - 2026
DA - 2026/11/07
JO - Journal for ImmunoTherapy of Cancer
DO - 10.1136/jitc-2026-sitc2026.0211
UR - https://doi.org/10.1136/jitc-2026-sitc2026.0211
SN - 2051-1426
ER -